Pattern of malignant disorders in individuals with Down's syndrome.
about
Understanding the basis for Down syndrome phenotypes.Treatment and prognostic impact of transient leukemia in neonates with Down syndromeHematological disorders and leukemia in children with Down syndrome.Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21.Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cellsDevelopmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesisPathogenic microRNA's in myeloid malignancies.Implications of copy number variation in people with chromosomal abnormalities: potential for greater variation in copy number state may contribute to variability of phenotype.Epidemiology of cancer in adolescents.Down syndrome--recent progress and future prospects.Non congenital heart disease aspects of Down's syndrome.Exploration of the treatment challenges in men with intellectual difficulties and testicular cancer as seen in Down syndrome: single centre experience.Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.Leukaemia -- a developmental perspective.Epidemiology and genetics of childhood cancer.The role of the chromatin assembly complex (CAF-1) and its p60 subunit (CHAF1b) in homeostasis and diseaseOrigins of leukaemia in children with Down syndrome.Down syndrome and genetics - a case of linked histories.Maternal and Birth Characteristics and Childhood Embryonal Solid Tumors: A Population-Based Report from Brazil.Chromosome copy number and leukemia-lessons from Down's syndrome.Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome.Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1)Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.Constitutional aneuploidy and cancer predisposition.Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease.Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndromeGATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorderTongue carcinoma in an adult Down's syndrome patient: a case reportDevelopment of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.Banding cytogenetic analysis in pediatric patients with acute lymphoblastic leukemia (ALL) in a Brazilian population.Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.Unique clinical and biological features of leukemia in Down syndrome children.Aging and intellectual disability: insights from mouse models of Down syndrome.Stem and progenitor cell dysfunction in human trisomies.SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.Background radiation and childhood leukemia: A nationwide register-based case-control study.
P2860
Q33238943-1025BB2A-82F4-4A58-AC4A-FEDD1B4C6329Q33378192-BB73B23C-DD2C-4871-874C-CE7BD2FEA446Q33398426-CD84A1BB-0046-480C-B413-3A6D22E86404Q33611301-7F265522-0DF0-4097-ADD5-99030F218AB7Q33685173-D16EC439-7285-4F03-8170-71B67585B58AQ33886396-81A604AA-0CF2-4814-B164-298C69EA2342Q33943930-B9FCE6D6-7BC8-4FC8-B0B5-83ABB5EEE57AQ34030154-4FFB07BD-7457-4450-811E-821DC511707BQ34541057-17CF40C5-02B1-4465-A543-D4DDB506A2B6Q34634523-C1AD8579-E152-4DD5-B8B5-6A68B0833C2DQ34811293-E500FEAA-76DE-4B0D-8843-30884C9EB2EFQ34964947-F125E32F-62F2-48DD-AE88-FBF2C2B79F53Q35597736-ED9E43FB-7976-44F5-B50A-15E451D6814AQ35678021-76A63917-76AF-4A76-938A-EFAF56C3EDEDQ35780831-43549750-7F61-4112-956E-6B63A9F0AA98Q35805989-18F34EA9-52AF-4676-8B90-3B394B010B10Q35868038-40673BE0-CE88-420E-A8AB-9E486879C968Q35890006-A0C24151-3229-4903-B13F-CDA418419278Q35998756-E8B696BB-0AD2-4683-BFB2-406847F1529CQ36004582-2ECBFA97-6CFB-4A81-B0C9-61C249CA9A27Q36170740-7688B4FD-8D3F-4DB7-9322-3D60CE20B46CQ36270036-87E339AA-00F9-48FD-BAD5-733FC8A2341BQ36344071-5D4C8C42-D5FA-4D6D-842B-DA8891C4C927Q36361480-579F6A39-94A8-4068-9278-DC81B0F60F14Q36581939-7E85C178-AE66-4F18-980C-32AA7506AA42Q36681400-DF96FA4B-4FE7-4C44-B605-FFC72E3B3690Q37134129-71534339-0D19-48EC-AF5A-CC09EA322631Q37137397-4BABC4FE-304D-4ACA-9E96-856F283375E3Q37142140-E628E410-2CB1-40CC-B9C5-5EEAAB28D1E7Q37147784-A7AFFBD1-9DD7-4FDA-953F-D7D9BA9B9A06Q37148906-80B7E853-90B4-4813-B7BC-BA3A2418749BQ37215179-D0B776DF-DE4F-40B4-AA72-DB0936EB65F4Q37346340-D04F77E0-7ADD-4EB6-80EA-77849A3728CBQ37364845-0D2DFCB4-B20E-4908-9E8B-97E04214E434Q37429718-53A412FF-C8DC-4D58-A525-AF5FCC6306D9Q37810271-E391AD34-05BD-4981-8F4B-DFA1F8BF4432Q38129324-3D51205A-5AD0-44E7-862B-5ED739755582Q38292512-A736C827-EDD2-45F2-80DD-2AB8EB25E056Q38904944-A79B48BC-2C6B-4E8C-A332-A976567EA974Q39609616-90A8D471-FB91-440A-90C7-DD694BE401E6
P2860
Pattern of malignant disorders in individuals with Down's syndrome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pattern of malignant disorders in individuals with Down's syndrome.
@ast
Pattern of malignant disorders in individuals with Down's syndrome.
@en
Pattern of malignant disorders in individuals with Down's syndrome.
@nl
type
label
Pattern of malignant disorders in individuals with Down's syndrome.
@ast
Pattern of malignant disorders in individuals with Down's syndrome.
@en
Pattern of malignant disorders in individuals with Down's syndrome.
@nl
prefLabel
Pattern of malignant disorders in individuals with Down's syndrome.
@ast
Pattern of malignant disorders in individuals with Down's syndrome.
@en
Pattern of malignant disorders in individuals with Down's syndrome.
@nl
P1433
P1476
Pattern of malignant disorders in individuals with Down's syndrome
@en
P2093
P304
P356
10.1016/S1470-2045(00)00435-6
P50
P577
2001-07-01T00:00:00Z